HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hypnic headache responsive to low-dose topiramate: a case report.

Abstract
This is a clinical report of a 63-year-old woman, with a 3-year history of severe episodes of hypnic headache responding to low-doses of topiramate (25 mg at bedtime). Topiramate has been used at the dosage of 100 mg/day for hypnic headache prevention in one recent case report with benefit. This report confirms the efficacy of topiramate in hypnic headache even using low-dose regimen therapy.
AuthorsMassimo Autunno, Corrado Messina, Anita Blandino, Carmelo Rodolico
JournalHeadache (Headache) Vol. 48 Issue 2 Pg. 292-4 (Feb 2008) ISSN: 0017-8748 [Print] United States
PMID18081825 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Neuroprotective Agents
  • Topiramate
  • Fructose
Topics
  • Dose-Response Relationship, Drug
  • Female
  • Fructose (analogs & derivatives, therapeutic use)
  • Headache Disorders, Primary (drug therapy)
  • Humans
  • Middle Aged
  • Neuroprotective Agents (therapeutic use)
  • Topiramate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: